Mazziotti G, Chiavistelli S, Giustina A (2015) Pituitary diseases and bone. Endocrinol Metab Clin North Am 44(1):171–180 Epub 20141104. https://doi.org/10.1016/j.ecl.2014.10.014

Article  PubMed  Google Scholar 

Mazziotti G, Frara S, Giustina A (2018) Pituitary Diseases and Bone. Endocr Rev.;39(4):440– 88. https://doi.org/10.1210/er.2018-00005. PubMed PMID: 29684108

Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab 34(4):231–242 Epub 2023/03/04. https://doi.org/10.1016/j.tem.2023.01.006

Article  CAS  PubMed  Google Scholar 

Mancini T, Casanueva FF, Giustina A (2008) Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 37(1):67–99 viii. Epub 2008/01/30. https://doi.org/10.1016/j.ecl.2007.10.013

Article  CAS  PubMed  Google Scholar 

Petersenn S, Giustina A (2020) Diagnosis and management of prolactinomas: current challenges. Pituitary.;23(1):1–2. https://doi.org/10.1007/s11102-019-01025-y. PubMed PMID: 31900881

Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G et al (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43(6):1003–1037. https://doi.org/10.1210/endrev/bnac010PubMed PMID: 35395078; PubMed Central PMCID: PMCPMC9695123

Article  PubMed  PubMed Central  Google Scholar 

Castle-Kirszbaum M, Biermasz N, Kam J, Goldschlager T (2024) Quality of life in Prolactinoma: a systematic review. Pituitary 27(3):239–247 Epub 20240424. https://doi.org/10.1007/s11102-024-01392-1

Article  PubMed  PubMed Central  Google Scholar 

Gold T, Williams SA, Weiss RJ, Wang Y, Watkins C, Carroll J et al (2019) Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey. J Drug Assess 8(1):175–183 PubMed PMID: 31692954; PubMed Central PMCID: PMCPMC6818103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Reviews Endocrinol 19(12):722–740. https://doi.org/10.1038/s41574-023-00886-5

Article  Google Scholar 

Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A et al (2020) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal Osteoporosis—2020 Update. Endocr Pract 26:1–46. https://doi.org/10.4158/GL-2020-0524SUPPL

Article  PubMed  Google Scholar 

Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R et al (2000) Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin Endocrinol (Oxf).;52(3):319– 27. https://doi.org/10.1046/j.1365-2265.2000.00902.x. PubMed PMID: 10718830

Cann CE, Martin MC, Genant HK, Jaffe RB (1984) Decreased spinal mineral content in amenorrheic women. JAMA 251(5):626–629 PubMed PMID: 6690836

Article  CAS  PubMed  Google Scholar 

Schlechte J, el-Khoury G, Kathol M, Walkner L (1987) Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 64(5):1021–1026. https://doi.org/10.1210/jcem-64-5-1021PubMed PMID: 3558723

Article  CAS  PubMed  Google Scholar 

Koppelman MC, Kurtz DW, Morrish KA, Bou E, Susser JK, Shapiro JR et al (1984) Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab 59(6):1050–1053. https://doi.org/10.1210/jcem-59-6-1050PubMed PMID: 6490793

Article  CAS  PubMed  Google Scholar 

Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M et al (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299–306. https://doi.org/10.1007/s11102-011-0293-4PubMed PMID: 21301967

Article  CAS  PubMed  Google Scholar 

Andereggen L, Frey J, Andres RH, Luedi MM, Widmer HR, Beck J et al (2021) Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas. Sci Rep 11(1):5122 Epub 20210304. https://doi.org/10.1038/s41598-021-84606-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mazziotti G, Porcelli T, Mormando M, De Menis E, Bianchi A, Mejia C et al (2011) Vertebral fractures in males with prolactinoma. Endocrine 39(3):288–293

Article  CAS  PubMed  Google Scholar 

Greenspan SL, Oppenheim DS, Klibanski A (1989) Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110(7):526–531

Article  CAS  PubMed  Google Scholar 

Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McARTHUR JW (1980) Decreased bone density in hyperprolactinemic women. N Engl J Med 303(26):1511–1514

Article  CAS  PubMed  Google Scholar 

Schlechte JA, Sherman B, Martin R (1983) Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab 56(6):1120–1123. https://doi.org/10.1210/jcem-56-6-1120PubMed PMID: 6404918

Article  CAS  PubMed  Google Scholar 

Seriwatanachai D, Krishnamra N, Van Leeuwen J (2009) Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. J Cell Biochem 107(4):677–685

Article  CAS  PubMed  Google Scholar 

Klibanski A, Greenspan SL (1986) Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 315(9):542–546

Article  CAS  PubMed  Google Scholar 

Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW et al (2017) Long-term Follow-Up of Primary Medical Versus Surgical treatment of Prolactinomas in men: effects on Hyperprolactinemia, Hypogonadism, and Bone Health. World Neurosurg 97:595–602 Epub 20161020. https://doi.org/10.1016/j.wneu.2016.10.059

Article  PubMed  Google Scholar 

Dzialach L, Sobolewska J, Zak Z, Respondek W, Witek P (2024) Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment. Front Endocrinol (Lausanne) 15:1338345 Epub 20240202. https://doi.org/10.3389/fendo.2024.1338345

Article  PubMed  Google Scholar 

Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M et al (2022) Italian Association of Clinical Endocrinologists (AME) and international chapter of clinical endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. Eur J Endocrinol 186(3):P1–p33 Epub 20220203. https://doi.org/10.1530/eje-21-0977

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847–875 Epub 20211020. https://doi.org/10.1016/s2213-8587(21)00235-7

Article  PubMed  PubMed Central  Google Scholar 

Pekić S, Medic Stojanoska M, Popovic V (2019) Hyperprolactinemia/Prolactinomas in the postmenopausal period: challenges in diagnosis and management. Neuroendocrinology 109(1):28–33 Epub 2018/10/23. doi: 10.1159/000494725. PubMed PMID: 30347396

Article  PubMed  Google Scholar 

Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS et al (2017) Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a Pituitary Society Statement. Pituitary 20(5):489–498. https://doi.org/10.1007/s11102-017-0838-2PubMed PMID: 28884415; PubMed Central PMCID: PMCPMC5606938

Article  PubMed  PubMed Central  Google Scholar 

Frara S, Rodriguez-Carnero G, Formenti AM, Martinez-Olmos MA, Giustina A, Casanueva FF (2020) Pituitary Tumors Centers of Excellence. Endocrinol Metab Clin North Am 49(3):553–564 Epub 20200715. https://doi.org/10.1016/j.ecl.2020.05.010

Article  PubMed  Google Scholar 

Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary. 2024. Epub 20240604. https://doi.org/10.1007/s11102-024-01397-w. PubMed PMID: 38833044

Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583–596 Epub 20230828. https://doi.org/10.1007/s11102-023-01345-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Couselo M, Frara S, Giustina A, Casanueva FF (2022) Pituitary tumor centers of excellence for Cushing’s disease. Pituitary 25(5):772–775 Epub 20220910. doi: 10.1007/s11102-022-01264-6. PubMed